Back
Protalix BioTherapeutics Stock Price Chart
Should You Invest in this AI Marketing High-Growth Startup by April?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
34
PLX
Protalix BioTherapeutics
Last Price:
$2.23
Seasonality Move:
1.71%
7 Day Trial
ALL ACCESS PASS
$
7
AI Is Disrupting Marketing - Invest in the Shift
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protalix BioTherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.29 | Sell |
| 20-day SMA: | 2.4 | Sell |
| 50-day SMA: | 2.34 | Sell |
| 200-day SMA: | 1.49 | Buy |
| 8-day EMA: | 2.28 | Sell |
| 20-day EMA: | 2.34 | Sell |
| 50-day EMA: | 2.25 | Sell |
| 200-day EMA: | 1.73 | Buy |
Protalix BioTherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 41.63 | Sell |
| Chaikin Money Flow: | 695964 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.28 - 2.6) | Sell |
| Bollinger Bands (100): | (1.4 - 2.4) | Buy |
Protalix BioTherapeutics Technical Analysis
| Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 2.24 while PLX 8-day simple moving average is 2.29, which is a Sell signal.
-
The stock price of PLX is 2.24 while Protalix BioTherapeutics 20-day SMA is 2.40, which makes it a Sell.
-
Protalix BioTherapeutics 50-day simple moving average is 2.34 while PLX share price is 2.24, making it a Sell technically.
-
PLX stock price is 2.24 and Protalix BioTherapeutics 200-day simple moving average is 1.49, creating a Buy signal.
PLX Technical Analysis vs Fundamental Analysis
Sell
34
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a SellThe current Protalix BioTherapeutics [PLX] share price is $2.24. The Score for PLX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
164.9M
Price in USD:
2.24
Share Volume:
696K
Protalix BioTherapeutics 52-Week Range
52-Week High:
2.76
52-Week Low:
0.82
Sell
34
Protalix BioTherapeutics (PLX)
is a Sell
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?The Protalix BioTherapeutics stock price is 2.24 USD today.
-
Will PLX stock go up or go down?Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protalix BioTherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is overvalued.
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 2.24 while PLX 8-day exponential moving average is 2.28, which is a Sell signal.
-
The stock price of PLX is 2.24 while Protalix BioTherapeutics 20-day EMA is 2.34, which makes it a Sell.
-
Protalix BioTherapeutics 50-day exponential moving average is 2.25 while PLX share price is 2.24, making it a Sell technically.
-
PLX stock price is 2.24 and Protalix BioTherapeutics 200-day simple moving average is 1.73, creating a Buy signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
-
PLX Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Protalix BioTherapeutics is a Sell
-
Protalix BioTherapeutics Relative Strength Index (RSI) is 41.63, which suggest Protalix BioTherapeutics is oversold
-
The Bollinger Bands (25) for Protalix BioTherapeutics is (2.28 - 2.6), which suggest Protalix BioTherapeutics is a Buy
-
The Bollinger Bands (100) for Protalix BioTherapeutics is (1.4 - 2.4), which suggest Protalix BioTherapeutics is a Buy
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.